Head-to-Head Study Comparing Navidea’s AZD4694 to the Gold Standard for Imaging Beta Amyloid Protein Deposits Presented at Alzheimer's Association International Conference Jul 23, 2012
Navidea Biopharmaceuticals Announces the Presentation of Data at Upcoming Scientific Meetings in July Jul 6, 2012
Navidea Biopharmaceuticals Elects to Extend Evaluation Period for Option to License Parkinson's Disease Imaging Agent Jun 26, 2012
Data Comparing Navidea’s AZD4694 to Gold-Standard 11C-PIB in Beta Amyloid Imaging Presented at Society of Nuclear Medicine Meeting Jun 11, 2012
Governor Patrick, Industry Representatives Join Navidea Biopharmaceuticals to Open New Business and Commercialization Facility in Andover, MA Jun 7, 2012
Navidea Biopharmaceuticals Announces the Presentation of Data at Society of Nuclear Medicine Annual Meeting in June Jun 6, 2012
Meta-analysis of Navidea Biopharmaceuticals Lymphoseek® Phase 3 Data Compared to Standard of Care Techniques Published in Conjunction with the ASCO Annual Meeting Jun 4, 2012
Navidea Biopharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference May 30, 2012
Presentation Highlights Clinical Potential of Navidea Biopharmaceuticals’ β-Amyloid Imaging Biomarker AZD4694 May 29, 2012
